TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 4643216)

Published in Sci Rep on November 13, 2015

Authors

Ronak Dixit1, Carolyn Kemp1, Scott Kulich2, Raja Seethala3, Simion Chiosea3, Shizhang Ling4, Patrick K Ha4, Umamaheswar Duvvuri1,2

Author Affiliations

1: Department of Otolaryngology, University of Pittsburgh, Pittsburgh, Pennsylvania USA.
2: VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania USA.
3: Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania USA.
4: Department of Otolaryngology, Johns Hopkins University School of Medicine, Baltimore, Maryland USA.

Articles citing this

Cellular functions of TMEM16/anoctamin. Pflugers Arch (2016) 0.89

MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression. J Exp Clin Cancer Res (2017) 0.75

Articles cited by this

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov (2012) 26.98

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal (2013) 19.54

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst (2008) 12.77

TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science (2008) 8.74

A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol (2008) 2.68

TMEM16A inhibitors reveal TMEM16A as a minor component of calcium-activated chloride channel conductance in airway and intestinal epithelial cells. J Biol Chem (2010) 2.66

Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites. Clin Cancer Res (2011) 2.31

TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression. Cancer Res (2012) 1.98

High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci U S A (2002) 1.46

Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers. Cancer Biol Ther (2009) 1.45

The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med (2011) 1.40

Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis. Eur J Cancer (2005) 1.36

Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res (1995) 1.29

Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. J Oncol (2012) 1.27

Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas. Oral Oncol (2014) 1.08

To "grow" or "go": TMEM16A expression as a switch between tumor growth and metastasis in SCCHN. Clin Cancer Res (2014) 1.05

Human papilloma virus positive oropharyngeal squamous cell carcinoma: a growing epidemic. Cancer Treat Rev (2013) 1.02